Alzheimer's disease (AD) is characterized by the presence of senile plaques composed primarily of deposits of the beta-amyloid protein (A- beta). A-beta is an about 4 kD peptide derived from larger amyloid precursor proteins (APP). We used low-stringency hybridization to identify mouse cDNA that encode APLP2, a member of APP gene family. APLP2 is highly homologous to mouse APP-751 within the Kunitz protease inhibitor domain, the N-terminal cysteine-rich region, and the cytoplasmic domains. APLP2 mRNA is expressed at significant levels in the brain and peripheral tissues of mouse. In vitro studies in cell-free translation systems and transfected cells reveal that APLP2 matures through the secretory pathway. Similarities in constitutive maturation of APP and APLP2 strongly suggest that enzymes with overlapping specificities may be involved in posttranslational modification of these polypeptides. Furthermore, our demonstration, by in situ hybridization, that APLP2 and APP mRNA are expressed in similar neuronal subsets in mouse grain suggests that APLP2 and APP expression may be controlled by similar genetic elements. We propose to address two issues that relate APLP2 expression. The first series of experiments are designed to examine whether APLP2 can compete with enzymes used for APP maturation to assess whether these proteins utilize identical pathways. In these studies, we will compare the maturation of APP in cells transfected with APP cDNA alone or in cells cotransfected with APP and APLP2 cDNA. In parallel, we will use epitope tags in coimmunoprecipitation studies to assess whether APP and APLP2 interact physically following expression in transfected cells. Secondly, we will isolate the APLP2 promoter and characterize its expression in transfected cells, using reported gene strategies. The promoter fragment will then be used in conjunction with a Lac Z reporter to examine the expression of the APLP2 promoter during development in transgenic mice. The possible influence of APLP on the biology of APP are not known; these studies represent a first step in the new and important area of research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005146-12
Application #
3745790
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Seddighi, Sahba; Varma, Vijay R; An, Yang et al. (2018) SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging. J Alzheimers Dis 61:401-414
Fredericks, Carolyn A; Sturm, Virginia E; Brown, Jesse A et al. (2018) Early affective changes and increased connectivity in preclinical Alzheimer's disease. Alzheimers Dement (Amst) 10:471-479
Holingue, Calliope; Wennberg, Alexandra; Berger, Slava et al. (2018) Disturbed sleep and diabetes: A potential nexus of dementia risk. Metabolism 84:85-93
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
van Bergen, Jiri M G; Li, Xu; Quevenco, Frances C et al. (2018) Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old. Neurobiol Aging 64:68-75
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Kim, Sangjune; Yun, Seung Pil; Lee, Saebom et al. (2018) GBA1 deficiency negatively affects physiological ?-synuclein tetramers and related multimers. Proc Natl Acad Sci U S A 115:798-803
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Hohman, Timothy J; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol 75:989-998

Showing the most recent 10 out of 830 publications